Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Tyro3, Axl Ve Mer (TAM) Receptors On Surfaces of Mononuclear Cells in Patients with B-Cell Chronic Lymphocytic Leukemia

Dilvin Guney, Aysin Tulunay, PhD, Funda Pepedil, MD, Isik Kaygusuz, MD, Cafer Adiguzel, MD, Tülin Tuglular, MD, Muzaffer Demir, MD, Emel Eksioglu-Demiralp, MD, Fikriye Uras

Blood (2012) 120 (21): 4588.

https://doi.org/10.1182/blood.V120.21.4588.4588

Published: 2012

Journal Articles

Inflammatory and Thrombotic Mediators in Small Cell Lung Carcinoma: Potential Role in Thromboembolic Complications

Debra Hoppensteadt, Ph.D., Hussein Khan, Indermohan Thethi, MD, Muzaffer Demir, MD, Cafer Adiguzel, MD, Saud Rahman, Jawed Fareed, PhD

Blood (2011) 118 (21): 2294.

https://doi.org/10.1182/blood.V118.21.2294.2294

Published: 2011

Journal Articles

Prevalence of Heparin Induced Thrombocytopenia Antibodies During the Period 2004–2011. Relevance to Heparin Contaminants

Jawed Fareed, PhD, Cafer Adiguzel, MD, Debra Hoppensteadt, Ph.D., Walter Jeske, Ph.D., Jeanine M. Walenga, PhD, Bruce E Lewis, MD, Harry L. Messmore, Jr., MD, Vinod Bansal, MD

Blood (2011) 118 (21): 4326.

https://doi.org/10.1182/blood.V118.21.4326.4326

Published: 2011

Journal Articles

A Higher Prevalence of HIT Antibodies in Patients May Be Due to Contaminated Heparin

Vinod Bansal, Josephine Cunanan, Cafer Adiguzel, Evangelos Litinas, Kelly Nelson, Jawed Fareed

Blood (2008) 112 (11): 3022.

https://doi.org/10.1182/blood.V112.11.3022.3022

Published: 2008

Journal Articles

Defibrotide Augments the Anticoagulant Actions of Heparin and Low Molecular Weight Heparins

Jawed Fareed, Ph.D., Omer Iqbal, M.D., Debra Hoppensteadt, Ph.D., Cafer Adiguzel, M.D., Massimo Iacobelli, M.D., Jeanine M. Walenga, Ph.D.

Blood (2008) 112 (11): 4086.

https://doi.org/10.1182/blood.V112.11.4086.4086

Published: 2008

Journal Articles

Molecular and Functional Heterogeneity in Contaminants Isolated from Recalled Heparin. Impact on Anticoagulation and Potential Adverse Reactions

Jawed Fareed, Ph.D., Debra Hoppensteadt, Ph.D., Walter Jeske, Ph.D., Cafer Adiguzel, MD, Omer Iqbal, MD, Jeanine M. Walenga, PhD

Blood (2008) 112 (11): 4048.

https://doi.org/10.1182/blood.V112.11.4048.4048

Published: 2008

Journal Articles

Fibrinokinetic Deficit in Chronic Kidney Disease and End Stage Renal Disease Patients Contributes to the Hemostatic Abnormalities

Cafer Adiguzel, Vinod Bansal, Josephine Cunanan, Evangelos Litinas, Debra Hoppensteadt, Jawed Fareed

Blood (2008) 112 (11): 4078.

https://doi.org/10.1182/blood.V112.11.4078.4078

Published: 2008

Journal Articles

Increased Levels of Anaphylatoxin (C5a) and Bradykinin in End-Stage Renal Disease Patients on Maintenance Hemodialysis. Potential Relevance to Heparin Mediated Hemodynamic Responses

Cafer Adiguzel, Vinod Bansal, Josephine Cunanan, Evangelos Litinas, Debra Hoppensteadt, Jawed Fareed

Blood (2008) 112 (11): 4079.

https://doi.org/10.1182/blood.V112.11.4079.4079

Published: 2008

Journal Articles

Selective Serotonin Reuptake Inhibitors Influence Agonist-Induced Platelet Aggregation. Preliminary Results from Comorbidity of Depression and Cardiovascular Disease Study

Omer Iqbal, Cafer Adiguzel, MD, Jawed Fareed, PhD, Debra Hoppensteadt, PhD, Evangalos Litinas, MD, He Zhu, MD, Angelos Halaris, MD

Blood (2008) 112 (11): 4556.

https://doi.org/10.1182/blood.V112.11.4556.4556

Published: 2008

Journal Articles

Relative Immunologic Potential of Bovine Prothrombin and Purified Thrombins

He Zhu, MD, Debra Ann Hoppensteadt, Ph.D., Rodger L. Bick, MD, PhD, Cafer Adiguzel, MD, Rakesh Wahi, MD, Jawed Fareed, Ph.D.

Blood (2008) 112 (11): 5463.

https://doi.org/10.1182/blood.V112.11.5463.5463

Published: 2008

Journal Articles

Potency Adjusted Generic Versions of Argatroban Can Be Differentiated from Branded Argatroban in Thrombin Generation and Platelet Activation Assays.

Cafer Adiguzel, MD, Omer Iqbal, M.D., Michael Sammikannu, B.S., Josephine Cunanan, M.D., Walter Jeske, Ph.D., Debra Hoppensteadt, Ph.D., Jawed Fareed, Ph.D.

Blood (2007) 110 (11): 4007.

https://doi.org/10.1182/blood.V110.11.4007.4007

Published: 2007

Journal Articles

A Unique Biomarker Is Associated with the Prevalence of Functional Heparin Induced Thrombocytopenia (HIT) Associated Antibodies: Results from Proteomic (ProteinChip Array) Profiling of ELISA Positive HIT Plasma Samples.

Michelle R. Kujawski, PhD, Margaret Prechel, Ph.D., He Zhu, M.D., Jeanine Walenga, Ph.D., Debra Hoppensteadt, Ph.D., Josephine Cunanan, M.D., Cafer Adiguzel, M.D., Jawed Fareed, Ph.D.

Blood (2007) 110 (11): 3205.

https://doi.org/10.1182/blood.V110.11.3205.3205

Published: 2007

Journal Articles

Modulation of Platelet Function by Recombinant Thrombomodulin Hematologic Implications.

Cafer Adiguzel, MD, Omer Iqbal, M.D., Daniel Fareed, B.S., Debra Hoppensteadt, Ph.D., Walter Jeske, Ph.D., Michael Simmikannu, B.S., Jawed Fareed, Ph.D.

Blood (2007) 110 (11): 3898.

https://doi.org/10.1182/blood.V110.11.3898.3898

Published: 2007

Journal Articles

Upregulation of Microparticles and CD40 Ligand in Antiphospholipid Syndrome: Potential Implication in Inflammatory Responses and Thrombosis.

Nancy Fabbrini, BS, Debra Hoppensteadt, Ph.D., Harry Messmore, Ph.D., Rodger Bick, M.D., Ph.D., Cafer Adiguzel, M.D., Jawed Fareed, Ph.D.

Blood (2007) 110 (11): 1740.

https://doi.org/10.1182/blood.V110.11.1740.1740

Published: 2007

Journal Articles

Factor Xa Inhibitors Can Be Differentiated in Xa, IIa and Microparticle Generation and Other Whole Blood Based Assays.

Omer Iqbal, MD, Cafer Adiguzel, MD., Debra Hoppensteadt, PH.D., Josephine Cunannan, MD., Jawed Fareed, PH.D.

Blood (2007) 110 (11): 931.

https://doi.org/10.1182/blood.V110.11.931.931

Published: 2007

Journal Articles

Imatinib Does Not Inhibit Neutrophil Oxidative Burst Function in Patients with Chronic Myelogenous Leukemia (CML).

Emel Eksioglu-Demiralp, M.D., Ph.D., Peyman Bizargity, M.D., Cafer Adiguzel, M.D., Gozen Ozilhan, MSc., Mahmut Bayik, M.D.

Blood (2004) 104 (11): 4673.

https://doi.org/10.1182/blood.V104.11.4673.4673

Published: 2004

NARROW

Tyro3, Axl Ve Mer (TAM) Receptors On Surfaces of Mononuclear Cells in Patients with B-Cell Chronic Lymphocytic Leukemia

Inflammatory and Thrombotic Mediators in Small Cell Lung Carcinoma: Potential Role in Thromboembolic Complications

Prevalence of Heparin Induced Thrombocytopenia Antibodies During the Period 2004–2011. Relevance to Heparin Contaminants

A Higher Prevalence of HIT Antibodies in Patients May Be Due to Contaminated Heparin

Defibrotide Augments the Anticoagulant Actions of Heparin and Low Molecular Weight Heparins

Molecular and Functional Heterogeneity in Contaminants Isolated from Recalled Heparin. Impact on Anticoagulation and Potential Adverse Reactions

Fibrinokinetic Deficit in Chronic Kidney Disease and End Stage Renal Disease Patients Contributes to the Hemostatic Abnormalities

Increased Levels of Anaphylatoxin (C5a) and Bradykinin in End-Stage Renal Disease Patients on Maintenance Hemodialysis. Potential Relevance to Heparin Mediated Hemodynamic Responses

Selective Serotonin Reuptake Inhibitors Influence Agonist-Induced Platelet Aggregation. Preliminary Results from Comorbidity of Depression and Cardiovascular Disease Study

Relative Immunologic Potential of Bovine Prothrombin and Purified Thrombins

Potency Adjusted Generic Versions of Argatroban Can Be Differentiated from Branded Argatroban in Thrombin Generation and Platelet Activation Assays.

A Unique Biomarker Is Associated with the Prevalence of Functional Heparin Induced Thrombocytopenia (HIT) Associated Antibodies: Results from Proteomic (ProteinChip Array) Profiling of ELISA Positive HIT Plasma Samples.

Modulation of Platelet Function by Recombinant Thrombomodulin Hematologic Implications.

Upregulation of Microparticles and CD40 Ligand in Antiphospholipid Syndrome: Potential Implication in Inflammatory Responses and Thrombosis.

Factor Xa Inhibitors Can Be Differentiated in Xa, IIa and Microparticle Generation and Other Whole Blood Based Assays.

Imatinib Does Not Inhibit Neutrophil Oxidative Burst Function in Patients with Chronic Myelogenous Leukemia (CML).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only